ArticleMolecular therapy. Nucleic acids2025
Development of conditional-siRNA programmable riboswitch for targeting adverse cardiac remodeling.
Priyanka Gokulnath et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it